Genome-wide Kdm4 histone demethylase transcriptional regulation in Drosophila

被引:0
|
作者
Amy Tsurumi
Shuang Xue
Lin Zhang
Jinghong Li
Willis X. Li
机构
[1] Massachusetts General Hospital and Harvard Medical School,Department of Surgery
[2] Harvard Medical School,Department of Microbiology and Immunology
[3] Shriners Hospitals for Children-Boston®,Department of Medicine
[4] University of California at San Diego,undefined
来源
关键词
Kdm4; Histone methylation; Development; Epigenetics; Histone;
D O I
暂无
中图分类号
学科分类号
摘要
The histone lysine demethylase 4 (Kdm4/Jmjd2/Jhdm3) family is highly conserved across species and reverses di- and tri-methylation of histone H3 lysine 9 (H3K9) and lysine 36 (H3K36) at the N-terminal tail of the core histone H3 in various metazoan species including Drosophila, C.elegans, zebrafish, mice and humans. Previous studies have shown that the Kdm4 family plays a wide variety of important biological roles in different species, including development, oncogenesis and longevity by regulating transcription, DNA damage response and apoptosis. Only two functional Kdm4 family members have been identified in Drosophila, compared to five in mammals, thus providing a simple model system. Drosophila Kdm4 loss-of-function mutants do not survive past the early 2nd instar larvae stage and display a molting defect phenotype associated with deregulated ecdysone hormone receptor signaling. To further characterize and identify additional targets of Kdm4, we employed a genome-wide approach to investigate transcriptome alterations in Kdm4 mutants versus wild-type during early development. We found evidence of increased deregulated transcripts, presumably associated with a progressive accumulation of H3K9 and H3K36 methylation through development. Gene ontology analyses found significant enrichment of terms related to the ecdysteroid hormone signaling pathway important in development, as expected, and additionally previously unidentified potential targets that warrant further investigation. Since Kdm4 is highly conserved across species, our results may be applicable more widely to other organisms and our genome-wide dataset may serve as a useful resource for further studies.
引用
收藏
页码:1107 / 1121
页数:14
相关论文
共 50 条
  • [1] Genome-wide Kdm4 histone demethylase transcriptional regulation in Drosophila
    Tsurumi, Amy
    Xue, Shuang
    Zhang, Lin
    Li, Jinghong
    Li, Willis X.
    MOLECULAR GENETICS AND GENOMICS, 2019, 294 (05) : 1107 - 1121
  • [2] Unravelling KDM4 histone demethylase inhibitors for cancer therapy
    Baby, Stephin
    Valapil, Durgesh Gurukkala
    Shankaraiah, Nagula
    DRUG DISCOVERY TODAY, 2021, 26 (08) : 1841 - 1856
  • [3] Novel chemotype of histone demethylase family KDM4 inhibitors
    Siklos, Marton
    Korczynska, Magdalena
    Bates, Timothy
    Shoichet, Brian
    Fujimori, Danica
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [4] Advances in histone demethylase KDM4 as cancer therapeutic targets
    Lee, Dong Hoon
    Kim, Go Woon
    Jeon, Yu Hyun
    Yoo, Jung
    Lee, Sang Wu
    Kwon, So Hee
    FASEB JOURNAL, 2020, 34 (03): : 3461 - 3484
  • [5] Heme promotes transcriptional and demethylase activities of Gis1, a member of the histone demethylase JMJD2/KDM4 family
    Lal, Sneha
    Comer, Jonathan M.
    Konduri, Purna C.
    Shah, Ajit
    Wang, Tianyuan
    Lewis, Anthony
    Shoffner, Grant
    Guo, Feng
    Zhang, Li
    NUCLEIC ACIDS RESEARCH, 2018, 46 (01) : 215 - 228
  • [6] Targeting histone demethylase KDM4 for cancers driven by chimeric transcription factors
    Yang, Jun
    Singh, Shivendra
    Abu-Zaid, Ahmed
    Fang, Jie
    Davidoff, Andrew
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [7] Discovery of a first-in-class PROTAC degrader of histone lysine demethylase KDM4
    Rao, Danni
    Wang, Yiting
    Yang, Xiaolong
    Chen, Zhiwen
    Wu, Feifei
    Ren, Ran
    Sun, Yaoliang
    Lai, Yuanhui
    Peng, Lijie
    Yu, Lei
    Zhang, Zhang
    Xu, Shilin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 288
  • [8] Targeting the histone demethylase KDM4 subfamily as a potential therapeutic strategy in breast cancer
    Holowatyj, Andreana
    Ye, Qin
    Zhang, Lihong
    Wu, Jack
    Yang, Zeng-Quan
    CANCER RESEARCH, 2014, 74 (19)
  • [9] KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review
    Chin, Young-Won
    Han, Sun-Young
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (02) : 135 - 144
  • [10] Structural and Evolutionary Basis for the Dual Substrate Selectivity of Human KDM4 Histone Demethylase Family
    Hillringhaus, Lars
    Yue, Wyatt W.
    Rose, Nathan R.
    Ng, Stanley S.
    Gileadi, Carina
    Loenarz, Christoph
    Bello, Simon H.
    Bray, James E.
    Schofield, Christopher J.
    Oppermann, Udo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (48) : 41616 - 41625